iBio, a plant-based biotech developing and manufacturing biological products, has formed a joint venture with affiliates of Eastern Capital Limited to develop and manufacture plant-made pharmaceuticals. Eastern and iBio have capitalized a newly-formed subsidiary of iBio called iBio CMO LLC to create a contract manufacturing organization for development, scale-up and large-scale manufacturing of biologicals. The Eastern Affiliates contributed $15 million in cash to the venture for 30% of the e...